Altogether, the above data suggested that BPTF might bind to the −1384 to −1667 regions of the VEGF promoter to regulate its transcription in NSCLC cells, and such binding was inhibited by lumbrokinase treatment. This evidence concerns the gene BPTF and non-small cell lung carcinoma.